Form DRS - Draft Registration Statement:
SEC Accession No. 0001683168-25-002312
Filing Date
2025-04-07
Accepted
2025-04-07 17:07:41
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 446113
2 filename2.htm EX-1.1 51155
3 filename3.htm EX-4.13 96947
4 filename4.htm EX-4.14 92801
5 filename5.htm EX-10.27 249889
  Complete submission text file 0001683168-25-002312.txt   937976
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-07866 | Film No.: 25818948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)